Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis

IntroductionImmune reconstitution therapies (IRT) are highly effective therapies for multiple sclerosis (MS). Among IRT, we can distinguish partially selective therapies such as cladribine in tablets (CLAD) and non-selective therapies, which include alemtuzumab (ALEM). Today, it is known that these...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aleksandra Pogoda-Wesołowska, Ignacy Stachura, Arkadiusz Zegadło, Marzena Maciągowska-Terela, Karolina Sobolewska, Aleksander Dębiec, Jacek Staszewski, Adam Stępień
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-02-01
Col·lecció:	Frontiers in Neuroscience
Matèries:	reconstitution therapies multiple sclerosis atrophy volumetric changes cladribine tablets alemtuzumab
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fnins.2025.1531163/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!